Lesaka Technologies Inc. (LSK)
Johannesburg Exchange · South Africa · prices in ZAR · close of 22 Oct 2026
Key indicators
| Last close | ZAR 7,000.00 |
|---|---|
| 52-week range | 6,500.00 – 9,000.00 |
| Return, 1 month / 3 months | −2.0% / −8.7% |
| Return, 1 year / 3 years | −6.7% / −17.6% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 49.1% |
| Worst drawdown (1 year) | -22.9% |
| Average daily value traded | 162.43M ZAR |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Lesaka Technologies is a financial technology company based in South Africa that provides payment processing and transaction services. It serves merchants, small businesses and individual consumers, with a focus on people who have limited access to traditional banking. Its offerings include card and cash payment acceptance, money transfers, insurance products and payroll-related services delivered through retail outlets and digital channels across Southern Africa.
The shares are listed on the Johannesburg Exchange in South Africa under the code LSK, and the price on this page is in South African rand (ZAR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Lesaka Technologies Inc. (LSK) trades on the Johannesburg Exchange in South Africa. It last closed at ZAR 7,000.00 on 22 October 2026.
Its price-based Market X-Ray is 36 out of 100 (a weak price profile), ranking 178 of 238 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 6.7% and over the last three months it fell 8.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Johannesburg Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 34 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.1% | ||
| From 52-week high | -22.1% | ||
| Momentum | 23 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.7% | ||
| 6-month return | -19.5% | ||
| 12-month return, skipping the last month | -4.7% | ||
| Stability (higher is calmer) | 46 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 49.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -22.9% | ||
| Liquidity | 45 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 162.43M ZAR | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −12.5% |
|---|---|
| 1 month | −2.0% |
| 3 months | −8.7% |
| 6 months | −19.5% |
| 1 year | −6.7% |
| 3 years | −17.6% |
| 5 years | −13.2% |
Signals
| 50-day / 200-day average | 7,618.98 / 7,871.62 |
|---|---|
| Golden / death cross (60 days) | Death, 23 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 462.60 |
Technical summary
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Johannesburg Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.